Clinical trial

Observation or Upfront Cranial RT in Oncogene Mutated NSCLC With Asymptomatic BM: A Phase III RCT

NCT05236946

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2020-11-10

PhasePHASE3

Study timeline

Study start (actual)2020-11-10Date precision: day

Registry last updated2025-09-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asymptomatic Brain Metastasesunresolved

Driver Mutation Positive Non-small Cell Lung Cancerunresolved

Interventions

Stereotactic radiosurgery/whole brain radiotherapyRADIATION

Tyrosine kinase inhibitorDRUG

Sponsors & collaborators

Tata Memorial Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05236946 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.